Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China
· Delayed Price · Currency is CNY 35.25
+0.47 (1.35%)
Apr 29, 2026, 4:00 PM EDT
SHA:688163 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 48.6 | 51.79 | 44.29 | 38.77 | 64.2 | 76.48 | Upgrade
|
| Depreciation & Amortization | 19.29 | 19.29 | 19.97 | 17.16 | 14.9 | 15.04 | Upgrade
|
| Other Amortization | 0.24 | 0.24 | 0.37 | 0.24 | 0.24 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.08 | -0.08 | -1.44 | - | - | 0.25 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.72 | 0.72 | 1.03 | 0.02 | -0.95 | 1.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.18 | -9.18 | 1.01 | -10.33 | -16.04 | 0.79 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.74 | 0.79 | -0.53 | 0.6 | Upgrade
|
| Other Operating Activities | 12.89 | 0.54 | 3.21 | 4.39 | 0.19 | 0.83 | Upgrade
|
| Change in Accounts Receivable | -8.49 | -8.49 | -10.42 | -22.99 | 3.2 | -4.48 | Upgrade
|
| Change in Inventory | -1.83 | -1.83 | -1.56 | 6.13 | -4.33 | -0.48 | Upgrade
|
| Change in Accounts Payable | 6.04 | 6.04 | -4.32 | -0.5 | 7.87 | 1 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | 0.79 | Upgrade
|
| Operating Cash Flow | 69.7 | 60.53 | 50.25 | 32.82 | 67.91 | 92.29 | Upgrade
|
| Operating Cash Flow Growth | 36.35% | 20.46% | 53.12% | -51.67% | -26.41% | -6.17% | Upgrade
|
| Capital Expenditures | -78.52 | -59.61 | -59.37 | -28.67 | -26.46 | -27.61 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.13 | 0.13 | 0.01 | 0.02 | - | 0.33 | Upgrade
|
| Investment in Securities | -264.69 | -124.99 | 70.83 | -305 | -349.85 | -65 | Upgrade
|
| Other Investing Activities | 10.5 | 10.38 | 5.27 | 17.71 | 15.89 | 1.76 | Upgrade
|
| Investing Cash Flow | -332.59 | -174.09 | 16.73 | -315.94 | -360.42 | -90.52 | Upgrade
|
| Long-Term Debt Repaid | - | - | -1.15 | -0.69 | -1.34 | -1.31 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -1.15 | -0.69 | -1.34 | -1.31 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 790.61 | - | Upgrade
|
| Common Dividends Paid | -34.63 | -34.63 | -34.63 | -81.16 | -97.39 | - | Upgrade
|
| Dividends Paid | -34.63 | -34.63 | -34.63 | -81.16 | -97.39 | - | Upgrade
|
| Other Financing Activities | -0.81 | -0.69 | - | - | - | -2.7 | Upgrade
|
| Financing Cash Flow | -35.44 | -35.32 | -35.77 | -81.84 | 691.87 | -4.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | 0.05 | -0.03 | 0.16 | 0.49 | -0.12 | Upgrade
|
| Net Cash Flow | -298.29 | -148.83 | 31.19 | -364.81 | 399.85 | -2.36 | Upgrade
|
| Free Cash Flow | -8.83 | 0.93 | -9.12 | 4.15 | 41.46 | 64.68 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -90.00% | -35.91% | -19.58% | Upgrade
|
| Free Cash Flow Margin | -4.46% | 0.47% | -4.68% | 2.18% | 23.79% | 30.99% | Upgrade
|
| Free Cash Flow Per Share | -0.10 | 0.01 | -0.08 | 0.04 | 0.41 | 0.80 | Upgrade
|
| Cash Income Tax Paid | 18.3 | 18.63 | 13.33 | 25.02 | 12.86 | 16.85 | Upgrade
|
| Levered Free Cash Flow | -19.47 | -19.16 | -23.72 | -3.9 | 32.16 | 34.48 | Upgrade
|
| Unlevered Free Cash Flow | -19.47 | -19.16 | -23.45 | -3.5 | 32.58 | 34.93 | Upgrade
|
| Change in Working Capital | -2.79 | -2.79 | -18.93 | -18.22 | 5.9 | -2.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.